Reveals the inner workings of the tenacious Israeli-based company Esclint as it attempts to make its mark in the area of medical diagnostic imaging with the development and marketing of a nuclear magnetic resonator (NMR) scanner. Recovering from a late start into the NMR field, Esclint survived by making the best use of limited resources and creative decision making. From the Enterprise 3 series.
